Loxo Oncology, Inc. Operating Expenses
Loxo Oncology, Inc. reported Operating Expenses of $72.79 million for the 3-month period ending 2018-09-30, per its 10-Q filed 2018-11-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2018-11-08
- Loxo Oncology, Inc. operating expenses for the quarter ending 2018-09-30 was $72.79M, a 2.21% decline year-over-year.
- Loxo Oncology, Inc. operating expenses for the quarter ending 2018-06-30 was $57.30M, a 85.35% increase year-over-year.
- Loxo Oncology, Inc. operating expenses for the quarter ending 2018-03-31 was $44.18M, a 77.15% increase year-over-year.
- Loxo Oncology, Inc. operating expenses for the quarter ending 2017-12-31 was $43.41M.
- Loxo Oncology, Inc. operating expenses for fiscal 2017 was $173.70M, a 137.36% increase from fiscal 2016.
- Loxo Oncology, Inc. operating expenses for fiscal 2016 was $73.18M, a 102.85% increase from fiscal 2015.
- Loxo Oncology, Inc. operating expenses for fiscal 2015 was $36.08M.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2018-09-30 | $72.79M 10-Q · filed 2018-11-08 | $130.09M derived: sum of 2 quarters · filed 2018-11-08 | $174.27M 10-Q · filed 2018-11-08 | $217.68M derived: sum of 4 quarters · filed 2018-11-08 |
| 2018-06-30 | $57.30M 10-Q · filed 2018-08-09 | $101.48M 10-Q · filed 2018-08-09 | $144.89M derived: sum of 3 quarters · filed 2018-08-09 | $219.32M derived: sum of 4 quarters · filed 2018-11-08 |
| 2018-03-31 | $44.18M 10-Q · filed 2018-05-08 | $87.59M derived: sum of 2 quarters · filed 2018-05-08 | $162.03M derived: sum of 3 quarters · filed 2018-11-08 | $192.94M derived: sum of 4 quarters · filed 2018-11-08 |
| 2017-12-31 | $43.41M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $117.84M derived: sum of 2 quarters · filed 2018-11-08 | $148.75M derived: sum of 3 quarters · filed 2018-11-08 | $173.70M 10-K · filed 2018-03-01 |
| 2017-09-30 | $74.43M 10-Q · filed 2018-11-08 | $105.35M derived: sum of 2 quarters · filed 2018-11-08 | $130.29M 10-Q · filed 2018-11-08 | |
| 2017-06-30 | $30.91M 10-Q · filed 2018-08-09 | $55.85M 10-Q · filed 2018-08-09 | ||
| 2017-03-31 | $24.94M 10-Q · filed 2018-05-08 | |||
| 2016-12-31 | $73.18M 10-K · filed 2018-03-01 | |||
| 2015-12-31 | $36.08M 10-K · filed 2018-03-01 |